Viva-Api Labs Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 5.85 Cr
as on 17-11-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 89.40 Cr
as on 17-11-2024
- Revenue 697.06%
(FY 2023)
- Profit 1749.25%
(FY 2023)
- Ebitda 2196.52%
(FY 2023)
- Net Worth 49.05%
(FY 2023)
- Total Assets 16.81%
(FY 2023)
About Viva-Api Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 5.85 Cr.
The company currently has active open charges totaling ₹89.40 Cr.
Sunita Garg, Vijay Garg, and Jagdish Goel serve as directors at the Company.
- CIN/LLPIN
U24239PB2020PTC051031
- Company No.
051031
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Viva-Api Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdish Goel  | Additional Director | 01-Nov-2022 | Current |
| Sunita Garg | Director | 22-Apr-2020 | Current |
| Vijay Garg | Director | 22-Apr-2020 | Current |
Financial Performance and Corporate Structure Insights of Viva-Api Labs.
Viva-Api Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 697.06% increase. The company also saw a substantial improvement in profitability, with a 1749.25% increase in profit. The company's net worth Soared by an impressive increase of 49.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Viva-Api Labs?
In 2023, Viva-Api Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vivachem Intermediates Private LimitedActive 6 years 9 monthsSunita Garg and Vijay Garg are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Aug 2024 | ₹15.00 Cr | Open |
Axis Bank Limited Creation Date: 17 Feb 2022 | ₹25.00 Cr | Open |
Axis Bank Limited Creation Date: 06 Oct 2021 | ₹49.40 Cr | Open |
How Many Employees Work at Viva-Api Labs?
Viva-Api Labs has a workforce of 158 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Viva-Api Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viva-Api Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
